Ultima HCG 5000IU US

Human Chorionic Gonadotropin (HCG) is a potent polypeptide hormone present in pregnant women, primarily utilized in medical treatments for conditions such as cryptorchidism, female infertility, hypogonadism (low testosterone), and even for weight loss.

Additionally, HCG is frequently used by anabolic steroid users either during their cycle or as part of recovery after ceasing steroid use. When taken during steroid use, the purpose of HCG is to mitigate hormone suppression caused by steroids. When used after steroids, it assists in a more effective recovery process.

One of the main contemporary uses of HCG is its application in weight-loss regimens. The HCG diet has gained substantial popularity in Western medicine, although its overall effectiveness remains a contentious issue. The American Medical Association and the American Society of Bariatric Physicians have criticized the HCG diet, claiming that weight loss primarily results from the extreme caloric restriction inherent in the diet, which typically limits intake to around 500 calories daily. Analysis of HCG's metabolic effects reveals that it does not stimulate thyroid function, is not a beta-2 stimulant, does not suppress appetite, and lacks any properties associated with fat burning or thermogenic agents. Nevertheless, numerous practitioners have reported positive results with the HCG diet, but criticisms persist regarding the long-term health implications of such severe caloric restriction. Currently, there is no conclusive evidence to prove that weight loss attributed to the HCG diet would not occur without the hormone if the same caloric limitations were followed. The discussion around the efficacy of this diet is likely to persist for years to come.

The effects of HCG for users of anabolic steroids can be categorized into two main areas: post-cycle therapy (PCT) and on-cycle usage. The use of anabolic steroids significantly suppresses natural testosterone production, the extent of which depends on the specific steroids and dosages used. Following the cessation of steroids, testosterone production typically resumes, although this process is gradual and may be accompanied by symptoms related to low testosterone levels, which can hinder muscle retention as cortisol dominates in the absence of testosterone. Consequently, many steroid users implement a PCT plan to expedite recovery. While this will aid in the recovery process, it does not fully restore normal testosterone levels on its own, but ensures adequate testosterone for normal bodily functions as levels gradually increase.

Multiple PCT strategies can be adopted, most incorporating selective estrogen receptor modulators (SERMs) such as Nolvadex (Tamoxifen Citrate) or Clomid (Clomiphene Citrate). However, many have found that initiating a PCT plan with HCG prior to using SERMs enhances overall recovery. HCG mimics luteinizing hormone (LH) and prepares the body for subsequent SERM treatment, resulting in a more effective recovery.

Another benefit of HCG for anabolic steroid users is its use during steroid cycles. Steroid use often leads to testicular shrinkage due to the suppression of natural testosterone production. Supplementing with HCG during steroid cycles helps maintain testicular size. While this is mainly a cosmetic effect without strategic advantage, it could facilitate recovery after steroid use is discontinued. However, caution is warranted as excessive reliance on HCG for LH can develop, which poses risks. For low testosterone patients using HCG, this is less of a concern, but non-low testosterone individuals must carefully monitor use to avoid dependence on HCG. Overuse of HCG has caused more harm than anabolic steroids for many users, making responsible usage crucial.

Anabolic steroid users who take HCG during their cycles typically use a standard dosage of 250 IU every 4-5 days. This amount is typically sufficient for the desired outcomes without risking future natural testosterone production.

For PCT, there are two commonly recommended protocols. The first approach involves administering 1,500-4,000 IU every 3-4 days for 2-3 weeks, followed by the introduction of SERM therapy. The second, potentially more efficient option, consists of daily doses of 500-1,000 IU for ten consecutive days, followed again by SERM therapy.

When using HCG during PCT, timing is critical. If your steroid cycle concludes with long ester-based steroids, initiate HCG therapy ten days after the final injection, then begin SERM treatment after HCG use ends. Conversely, if you finish with short ester-based steroids, start HCG therapy three days post-injection, followed by SERM therapy once HCG administration is complete.